Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is 12.01.
Forward PE Ratio (12.01) = Close Price ($95.72) / Consensus Forward EPS ($8.00)
FORWARD PE RATIO
12.01
SECTOR MEDIAN · HEALTHCARE
19.76
median of 78 covered companies
CURRENT VS SECTOR MEDIAN
-39.21%
vs the sector median at left
CVS Health Corp.
Market Cap
$122.13B
Forward PE Ratio
12.01
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| CVS Health Corp. (CVS) | $122.13B | 12.01 |
| Intuitive Surgical, Inc. (ISRG)vs › | $124.01B | 32.42 |
| Medtronic plc (MDT)vs › | $118.19B | 16.74 |
| Bristol-Myers Squibb Company (BMY)vs › | $131.96B | 9.34 |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $132.36B | 28.21 |
| Stryker Corporation (SYK)vs › | $104.95B | 18.41 |
| McKesson Corporation (MCK)vs › | $104.74B | 22.79 |
| Sanofi (SNY)vs › | $103.24B | N/A |
| Danaher Corporation (DHR)vs › | $144.09B | 24.14 |
| GSK plc (GSK)vs › | $97.80B | 13.54 |
Trailing P/E
25.4
reported TTM EPS
Forward P/E
12.0
consensus next-FY EPS
The gap between the two multiples is the consensus growth expectation: analysts' forward EPS of $8.00 implies +111.6% EPS growth vs the reported trailing $3.78.
At today's $95.72 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $8.00 | $7.40 – $8.18 | 17 | 12.0x |
| 2027-12-31 | $8.50 | $8.25 – $8.93 | 18 | 11.3x |
| 2028-12-31 | $9.70 | $8.93 – $10.91 | 13 | 9.9x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
